{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T03:41:24Z","timestamp":1793936484330,"version":"4.8.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"29","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003443","name":"Ministry of Education and Science of the Russian Federation","doi-asserted-by":"publisher","award":["02.740.11.0877"],"award-info":[{"award-number":["02.740.11.0877"]}],"id":[{"id":"10.13039\/501100003443","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.vaccine.2015.04.073","type":"journal-article","created":{"date-parts":[[2015,5,11]],"date-time":"2015-05-11T17:30:15Z","timestamp":1431365415000},"page":"3398-3406","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Development of a candidate influenza vaccine based on virus-like particles displaying influenza M2e peptide into the immunodominant region of hepatitis B core antigen: Broad protective efficacy of particles carrying four copies of M2e"],"prefix":"10.1016","volume":"33","author":[{"given":"Liudmila M.","family":"Tsybalova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liudmila A.","family":"Stepanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor V.","family":"Kuprianov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena A.","family":"Blokhina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina V.","family":"Potapchuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander V.","family":"Korotkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrey N.","family":"Gorshkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina A.","family":"Kasyanenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolai V.","family":"Ravin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleg I.","family":"Kiselev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.04.073_bib0165","series-title":"Estimate of epidemiological efficacy live influenza vaccine during influenza outbreak in 1959. Etiology immunology and clinic characteristic of Asian influenza. Transaction of scientific papers. Transaction of the All-Union research institute of influenza","first-page":"200","author":"Smorodincev","year":"1961"},{"key":"10.1016\/j.vaccine.2015.04.073_bib0170","first-page":"381","article-title":"The Hong Kong influenza virus epidemic in the USSA","volume":"41","author":"Zdanov","year":"1969","journal-title":"Bull WHO"},{"key":"10.1016\/j.vaccine.2015.04.073_bib0175","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1098\/rstb.2001.0981","article-title":"Developing vaccines against pandemic influenza","volume":"356","author":"Wood","year":"2001","journal-title":"Phil Trans R Soc Lond B"},{"key":"10.1016\/j.vaccine.2015.04.073_bib0180","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/0092-8674(85)90211-9","article-title":"Influenza virus M2 protein is an integral membrane protein expressed on the infected-cell surface","volume":"40","author":"Lamb","year":"1985","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2015.04.073_bib0185","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/0092-8674(92)90452-I","article-title":"Influenza virus M2 protein has ion channel activity","volume":"69","author":"Pinto","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2015.04.073_bib0190","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1016\/S0264-410X(03)00040-9","article-title":"Induction of influenza type A virus specific resistance by immunization of mice with a synthetic multiple antigenic peptide vaccine that contains ectodomains of matrix protein 2","volume":"21","author":"Mozdzanowska","year":"2003","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2015.04.073_bib0195","doi-asserted-by":"crossref","first-page":"426","DOI":"10.3201\/eid1303.061125","article-title":"Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1","volume":"13","author":"Tompkins","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2015.04.073_bib0200","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1016\/j.vaccine.2004.02.021","article-title":"Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys","volume":"22","author":"Fan","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.04.073_bib0205","doi-asserted-by":"crossref","first-page":"4460","DOI":"10.1016\/j.vaccine.2011.04.040","article-title":"Characterization of the murine Th2 response to immunization with liposomal M2e influenza vaccine","volume":"29","author":"Adler-Moore","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.04.073_bib0210","doi-asserted-by":"crossref","first-page":"5481","DOI":"10.1016\/j.vaccine.2011.05.062","article-title":"Complete protection against a N5N1 avian influenza virus by DNA vaccine expressing a fusion protein of H1N1 HA and M2e","volume":"29","author":"Park","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.04.073_bib0215","doi-asserted-by":"crossref","first-page":"5587","DOI":"10.2174\/13816128113199990337","article-title":"Immunogenicity and protective efficacy of candidate universal influenza A nanovaccines produced in plants by tobacco mosaic virus-based vectors","volume":"19","author":"Petukhova","year":"2013","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.vaccine.2015.04.073_bib0220","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1016\/j.vaccine.2008.04.052","article-title":"Development of a universal influenza A vaccine based on the M2 peptide fused to the papaya mosaic virus (Pap MV) vaccine platform","volume":"26","author":"Denis","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.04.073_bib0225","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/13484","article-title":"A. Universal influenza A vaccine based on the extracellular domain of the M2 protein","volume":"5","author":"Neirynck","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2015.04.073_bib0230","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.virusres.2004.02.030","article-title":"A \u2018universal\u2019 human influenza A vaccine","volume":"103","author":"Fiers","year":"2004","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2015.04.073_bib0235","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.virol.2005.04.004","article-title":"Universal influenza A vaccine: optimization of M2-based constructs","volume":"337","author":"De Filette","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2015.04.073_bib0240","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.vaccine.2006.08.013","article-title":"Vaccination with recombinant fusion proteins incorporating Toll-like receptor ligands induces rapid cellular and humoral immunity","volume":"25","author":"Huleatt","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.04.073_bib0245","first-page":"33","article-title":"Plant-produced recombinant influenza vaccine based on virus-like HBc particles carrying an extracellular domain of M2 protein","volume":"77","author":"Ravin","year":"2012","journal-title":"Biochemistry"},{"key":"10.1016\/j.vaccine.2015.04.073_bib0250","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.virol.2012.09.014","article-title":"A molecular assembly system for presentation of antigens on the surface of HBc virus-like particles","volume":"435","author":"Blokhina","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2015.04.073_bib0255","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0065-3527(08)60808-8","article-title":"Core particles of hepatitis B virus as carrier for foreign epitopes","volume":"50","author":"Ulrich","year":"1998","journal-title":"Adv Virus Res"},{"key":"10.1016\/j.vaccine.2015.04.073_bib0260","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1126\/science.3491425","article-title":"The nucleocapsid of hepatitis B virus is both a T-cell-independent and a T-cell-dependent antigen","volume":"234","author":"Milich","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2015.04.073_bib0265","doi-asserted-by":"crossref","first-page":"6359","DOI":"10.1128\/JVI.75.14.6359-6366.2001","article-title":"Hepatitis B virus core antigen binds and activates naive human B cells in vivo: studies with a human PBL-NOD\/SCID mouse model","volume":"75","author":"Tinghua","year":"2001","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2015.04.073_bib0270","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/eji.200636959","article-title":"Efficient induction of mucosal and systemic immune responses by virus-like particles administered intranasally: implication for vaccine design","volume":"38","author":"De Fillete","year":"2008","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2015.04.073_bib0275","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1126\/science.8248784","article-title":"The influence of antigen organization on B cell responsiveness","volume":"262","author":"Bachmann","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2015.04.073_bib0280","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.vaccine.2007.10.062","article-title":"Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin","volume":"26","author":"Huleatt","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.04.073_bib0285","doi-asserted-by":"crossref","first-page":"6527","DOI":"10.1016\/j.vaccine.2012.08.054","article-title":"Enhanced immune response induced by a potential influenza A vaccine based on branched M2e polypeptides linked to tuftsin","volume":"30","author":"Liu","year":"2012","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2015.04.073_bib0290","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4149\/av_2011_01_61","article-title":"Heterosubtypic protective immunity against influenza A virus induced by fusion peptide of the hemagglutinin in comparison to ectodomain of M2 protein","volume":"55","author":"Stanekova","year":"2011","journal-title":"Acta Virol"},{"key":"10.1016\/j.vaccine.2015.04.073_bib0295","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1128\/jvi.62.8.2762-2772.1988","article-title":"Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions","volume":"62","author":"Zebedee","year":"1988","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2015.04.073_bib0300","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.intimp.2004.12.005","article-title":"The epitope recognized by a monoclonal antibody in influenza A virus M2 protein is immunogenic and confers immune protection","volume":"5","author":"Zou","year":"2005","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.vaccine.2015.04.073_bib0305","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1006\/viro.1998.9534","article-title":"Treatment of influenza virus-infected SCID mice with non-neutralizing antibodies specific for the transmembrane proteins matrix 2 and neuraminidase reduced the pulmonary virus titre but fails to clear the infection","volume":"254","author":"Mozdzanowska","year":"1999","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2015.04.073_bib0310","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/1743-422X-4-118","article-title":"Roles of adjuvant and route of vaccination in antibody response and protection engendered by asynthetic matrix protein 2-based influenza A virus vaccine in the mouse","volume":"4","author":"Mozdzanovska","year":"2007","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2015.04.073_bib0315","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/eji.201041225","article-title":"Universal vaccine against influenza virus: linking TLR signaling to anti-viral protection","volume":"42","author":"Schmiz","year":"2012","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2015.04.073_bib0320","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.4049\/jimmunol.0902147","article-title":"Universal vaccine based on ectodomain of matrix protein 2 of influenza A: Fc receptors and alveolar macrophages mediate protection","volume":"186","author":"EL Bakkouri","year":"2011","journal-title":"J Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15005496?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15005496?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:22:58Z","timestamp":1759400578000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15005496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":32,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S0264410X15005496"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.04.073","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a candidate influenza vaccine based on virus-like particles displaying influenza M2e peptide into the immunodominant region of hepatitis B core antigen: Broad protective efficacy of particles carrying four copies of M2e","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.04.073","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}